Darius Noori, M.D Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 204 S Riverside Dr, Moore, OK 73160 Phone: 405-759-2138 Fax: 405-759-2138 |
William Earl Tankersley Iv, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 604 S Classen Ave, Suite C, Moore, OK 73160 Phone: 405-799-0900 Fax: 405-799-0902 |
Clayton D Morris, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 604 S Classen Ave Ste C, Moore, OK 73160 Phone: 405-799-0900 Fax: 405-799-0902 |
Rachel Dalthorp, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 1105 Sw 30th Ct, Moore, OK 73160 Phone: 405-378-2727 Fax: 405-378-2776 |
Dr. Eduardo A. De Sousa, M.D. Psychiatry & Neurology - Neuromuscular Medicine Medicare: Accepting Medicare Assignments Practice Location: 1060 Sw 4th St, Moore, OK 73160 Phone: 405-302-2661 Fax: 405-302-2670 |
News Archive
Solos Endoscopy, Inc. is pleased to announce the Company has secured the U.S. Trademark for the MammoView® name. The MamoView® Breast Endoscopy System offers a state-of-the-art endoscopic technology for detecting early stage breast cancer. The Company's Breast Endoscopy System employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts, where the majority of breast cancers arise.
A team of researchers at the University of Ottawa Heart Institute, led by Dr. Alexandre Stewart, have uncovered an intriguing link between heart attacks and a protein that is of great interest to drug companies for its impact on cholesterol.
The Task Force for the National Conference on Diabetes issued a Call to Action today entitled Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact. This Call to Action is a result of the National Conference on Diabetes, held earlier this year in Washington, D.C., which was attended by nearly 100 participants representing the Administration, Congress, government officials, public health organizations and industry.
As busy people, we juggle many tasks, keep many balls in the air, and try to avoid letting anything drop. In class, instructors toss out ideas; sometimes they go over our heads, but other times we grasp them quickly.
DiaGenic ASA today announced that the first patient with MCI (Mild Cognitive Impairment) was examined with [18F] Flutemetamol PET imaging at University of Lund Sweden in the DiaGenic and GE Healthcare Research Collaboration announced March 27th 2012.
› Verified 4 days ago